Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections

American Surgeon

Volumn 69, Issue 6, 2003, Pages 514-519

  Joels, Charles S ^a   Matthews, Brent D ^a   Sigmon, Lee B ^a   Hasan, Reem ^a   Lohr, Charles E ^a   Kercher, Kent W ^a   Norton, James ^a   Sing, Ronald F ^a   Heniford, B Todd ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; COMORBIDITY; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL INFECTION; TREATMENT OUTCOME; URBAN POPULATION;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS INFECTION; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; URBAN POPULATION; VANCOMYCIN RESISTANCE;

EID: 0041765802     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Hendrix CW, Hammond JMJ, Swoboda SM, et al. Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients. Ann Surg 2000; 233:259-265
2. Sefton AM. Mechanism of antimicrobial resistance. Drugs 2002;62:557-566
3. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 2001;344:1427-1433
4. Siddiqui AH, Harris AD, Hebden J, et al. The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital- wide. Am J Infect Cont 2002;30:40-43 (Pubitemid 34155281)
5. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
6. Dahms RA, Johnson EM, Statz CL, et al. Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant Enterococcus infection. Arch Surg 1998; 133:1343-1346
7. Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 2001;29:N114-20.
8. Scagnelli M, Pellizer G, de Lalla F, et al. Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary- care hospital in Northern Italy. Eur J Clin Microbiol Infect Dis 2001;20:609-616 (Pubitemid 32953831)
9. Low DE, Keller N, Barth A, et al. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001;32:S133-45. (Pubitemid 32424267)
10. Gold HS. Vancomycin-resistant enterococci: Mechanisms and clinical observations. Clin Infect Dis 2001;33:210-219
11. Peset V, Tallon P, Sola C, et al. Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis 2000;19:742-749 (Pubitemid 30839921)
12. Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 1999;20:318-323
13. Edmond MB, Ober JF, Dawson JD, et al. Vancomycin- resistant enterococcal bacteremia: Natural history and attributable mortality. Clin Infect Dis 1996;23:1234-1239
14. Fleenor-Ford A, Hayden MK, Weinstein RA. Vancomycin- resistant enterococci: Implication for surgeons. Surgery 1999;125: 121-125
15. Barie PS. Antibiotic-resistant gram-positive cocci: Implications for surgical practice. World J Surg 1998;22:118-126
16. Mangram AJ, Horan TC, Pearson ML, et al. Guidelines for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20:250-280
17. Lucas GM, Lechtzin N, Puryear DW, et al. Vancomycin- resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes. Clin Infect Dis 1998;26:1127-1133 (Pubitemid 28215477)
18. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin- resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995;21:45-50.
19. Bakir M, Bova JL, Newell KA, et al. Epidemiology and clinical consequences of vancomycin-resistant Enterococci in liver transplant patients. Transplantation 2001;72:1032-1037 (Pubitemid 32924073)
20. Bhavnani SM, Drake JA, Forrest A, et al. A nationwide, multicenter, case-control study comparing the risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 2000;36: 145-158 (Pubitemid 30145652)
21. Kable AK, Gibberd RW, Spigelman AD. Adverse events in surgical patients in Australia. Int J Qual Health Care 2002;14: 269-276 (Pubitemid 34905557)
22. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343: 1925-1932
23. Carmeli Y, Samore MH, Huskins WC. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci. Arch Int Med 1999;159: 2461-2468 (Pubitemid 29526775)
24. Garbutt JM, Ventrapragada M, Littenberg B, et al. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 2000;30: 466-472 (Pubitemid 30205290)
25. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Recommendation of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995;23:87-94.
26. Huycke MM, Sahm DF, Gilmore MS. Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future. Emerg Infect Dis 1998;4:239-249
27. Lai KK. Treatment of vancomycin-resistant Enterococcus faecium infections. Arch Int Med 1996;156:2579-2584 (Pubitemid 26404795)
28. Linden PK. Treatment options for vancomycin-resistant enterococcal infections. Drugs 2002;62:425-441 (Pubitemid 34211023)